$HHSE.=.EXPONENTIAL-GROWTH--$50M+ in 2025, OTCQB.&.NASDAQ

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks louied91 #25121
117
$HHSE.=.EXPONENTIAL-GROWTH--$50M+ in 2025, OTCQB.&.NASDAQ ARE NEXT.

Hannover House (HHSE) Positioned for Huge Growth from New Products and Financing


Press Release | 01/10/2025

https://www.otcmarkets.com/stock/HHSE/news/Ha...?id=464170

New York, New York--(Newsfile Corp. - January 10, 2025) - Independent media company Hannover House (OTC: HHSE), is launching into the new year with a roar, fueled by high-profile new properties and major financing. The 31-year old publishing house and entertainment distributor is forecasting revenue activities that should collectively exceed $50 million this year, said CEO Eric Parkinson. Peak annualized revenues for the company hit $20-million in 2007, when the company had a dozen feature film titles in the DVD budget bins at Walmart and Target stores. But the slow decline of the DVD sell-through market in favor of in-home streaming, brought a significant drop in revenues for Hannover during the past 10 years - as the company worked to reinvent its business model to pursue more lucrative activities.

TRUMP BOOK Cover - a powerful new book that reveals secret strategies for campaign success.

"The success we are delivering now is the result of a tremendous amount of hard work and detailed, in-depth business analysis," said Parkinson. "Many independent entertainment companies did not survive the transition from physical DVDs and Blu-ray Discs in favor of the consumer preference for in-home streaming. We have since developed two product categories and two distribution strategies that address these current market trends for consumer preferences," he continued.

UNHOLY SONG Teaser Art - acclaimed new thriller from HHSE has already spawned a sequel production.

First up for HHSE this year is a highly touted new book from best-selling author, Barr McClellan. "AMERICAN MANIFESTO: The Unstoppable Journey of President Donald J. Trump" will hit bookstores in late February, following a major promotional partnership with both Truth Social and the "X" social media platform. The book goes behind-the-scenes of the Trump campaign in 2024, to reveal strategies that successfully attracted voters from demographic groups that were long presumed to be democratic strongholds. As such, the book has great historic value as well as providing enlightening insights for both Republicans and Democrats on effective campaign strategies.

Also, in late February, the company is releasing the acclaimed horror-thriller, UNHOLY SONG to approximately 350 theaters in the United States. The company is concentrating on booking the film into the top performing locations for other independent, horror titles, such as the recently released hit, "TERRIFIER 3, " which has already grossed over $90 million in worldwide revenues . HHSE feels that Unholy Song is on track to gross over $10 million for the company, as well as to spark a new franchise series. Hannover House has already green-lit production for UNHOLY SONG 2 , to be shot in northern California in July. Discussions are already underway for a third installment in the series as well.

Also releasing this spring to theaters is the long awaited family feature, WILDFIRE: The Legend of the Cherokee Ghost Horse, " starring Anne Heche, Mo Brings Plenty ("Yellowstone" and Adrian Paul ("Highlander" . The film premiered last November at the Lone Star Film Festival in Fort Smith - but was delayed from release in order to complete some new music tracks, picture tweaks, and a 7.1 surround mix. HHSE is targeting approximately 300 theatres for the April 18 theatrical release, before a high profile streaming debut. Hannover House is forecasting revenues of $5.5 million from this title.

On a higher profile front, the company has closed financing arrangements for two major feature productions that collectively will cost over $35 million to produce . These features will be announced in detail separately, but will have a significant and positive impact to the company balance sheet, as well as providing high profile locomotive titles for the company's distribution activities. Both of these features have major level stars attached.

Regarding the company's stock, HHSE has taken steps to improve access for investors interested in purchasing its stock shares. This has been done through a recently enacted policy change with E*TRADE financial, as well as the company's forthcoming application to up-list the stock to the OTC: QB markets trading platform. At present, the company stock is traded on the OTC pink sheets, which Parkinson feels has less credibility with major investors and stock traders than some of the higher profile exchanges.

TEMPUS PORTA Teaser art - a major featured production in 2025 from Hannover House.

Last, but not least, the company has spent several years in development for a video-on-demand streaming service called MyFlix. With over 40 supplier Studios representing more than 15,000 feature titles, the MyFlix service will provide a free-to-view platform for consumers (like TUBI) but with a greater concentration on independent features than any other streaming service. The capital required to launch MyFlix has been a challenge for Hannover House, until now. With significant pre-sales for many of the company's new product releases, Hannover House feels it can allocate a percentage of these spring and summer 2025 revenues to bankroll the launch of this exciting new streaming service.

"This is a very exciting time for the company," said Parkinson. "We survived, we adapted, and now we are reaping the benefits of a successful business strategy. We are grateful to our shareholders and financing partners who helped us navigate through a changing media environment and to help launch this exciting new business plan," he concluded.

For more information, contact:

ERIC PARKINSON, 818-481-5277, EnterLinkMedia@gmail.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 25

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Boussard & Gavaudan's NAV Report Highlights for Investors

Updated Category News Views 72

Boussard & Gavaudan Holding Limited: NAV Update Boussard & Gavaudan Holding Limited is pleased to provide a recent update regarding the company's net asset values (NAV) for its Ordinary Shares. Investors are encouraged to stay informed about the performance and returns associated with their investments. Current NAV Estimates The estimated NAV, as of the close of business,...

Continue Reading
Moab Launches Free Shuttle to Enhance Park Access

Updated Category News Views 11

Moab's Shuttle: A New Era for Park Access A breeze of change is sweeping through the dusty trails of Moab, Utah, and this isn't just any switch—it's about making the always-packed Arches National Park a bit less of a traffic nightmare. Imagine this: strolling up to a shuttle, no tickets, no cash needed, and you're off to see epic scenery like The Windows and Delicate...

Continue Reading
Grid Dynamics Shares Upcoming Financial Results Preview

Updated Category News Views 82

Overview of Upcoming Financial Results Announcement Grid Dynamics Holdings, Inc. (Nasdaq: GDYN), recognized as a frontrunner in the digital transformation sector, is preparing to announce its financial results for the fourth quarter and full year of the fiscal year 2024. This much-anticipated event is scheduled for February 20, 2025. Investors and stakeholders can look...

Continue Reading
BioSig Technologies and Streamex Successfully Close $15 Million Offering

Updated Category News Views 154

BioSig Technologies and Streamex Close $15 Million Offering BioSig Technologies, Inc. is excited to share that it has successfully completed a public offering, raising approximately $15 million. The company, now merged with Streamex Exchange Corporation (NASDAQ: BSGM), focuses on gold tokenization infrastructure, positioning itself as a leader in the industry. Details of...

Continue Reading
Navigate Wellbeing Solutions Achieves 2024 Workplace Excellence

Updated Category News Views 64

Navigating Towards Employee Satisfaction Navigate Wellbeing Solutions has proudly secured the Great Place To Work Certification™ for the year 2024. This recognition is a testament to the positive work environment fostered by the organization, as revealed by feedback from employees. An impressive 92% of team members agree it's a great place to work, significantly above...

Continue Reading